Treatment of thyrotoxicosis--the current position. 3. Radioiodine therapy. Special considerations.
D000328:Adult; D000367:Age Factors; D002231:Carbimazole / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D005260:Female; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D007037:Hypothyroidism / Q000209:etiology / Q000517:prevention & control; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D010102:Oxygen Inhalation Therapy; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D011433:Propranolol / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D012008:Recurrence; D013958:Thyroid Crisis / Q000628:therapy; D013961:Thyroid Gland / Q000528:radiation effects
D007457:Iodine Radioisotopes; D002231:Carbimazole; D011433:Propranolol; D002746:Chlorpromazine; D011241:Prednisone